The Searle Co (KAR:SEARL) Accounts Payable: ₨3,498 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:SEARL The Searle Co Ltd KAR:SEARL
73 GF Score
Price ₨90.84
GF Value ₨75.81
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is The Searle Co Accounts Payable?

The Searle Co KAR:SEARL +1.17% 73 Accounts Payable is ₨3,498 Mil as of Mar. 2026. GuruFocus rates KAR:SEARL with a GF Score™ of 73/100 and a GF Value™ of ₨75.81 (Modestly Overvalued). The stock has 3 warning signs investors should review.

The Searle Co's Accounts Payable for the quarter that ended in Mar. 2026 was ₨3,498 Mil.

The Searle Co's quarterly Accounts Payable increased from Sep. 2025 (₨3,289 Mil) to Dec. 2025 (₨5,097 Mil) but then declined from Dec. 2025 (₨5,097 Mil) to Mar. 2026 (₨3,498 Mil).

The Searle Co's annual Accounts Payable increased from Jun. 2023 (₨5,207 Mil) to Jun. 2024 (₨5,387 Mil) but then declined from Jun. 2024 (₨5,387 Mil) to Jun. 2025 (₨4,202 Mil).

The Searle Co Accounts Payable Related Terms

The Searle Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for The Searle Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Searle Co Accounts Payable Chart

The Searle Co Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,273.72 1,568.41 5,206.89 5,386.98 4,202.36

The Searle Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,085.70 4,202.36 3,289.26 5,096.60 3,498.37
KAR:SEARL
73GF Score
The Searle Co Ltd KAR:SEARL
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Searle Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₨3,498 Mil mean?
The Searle Co (KAR:SEARL) has a Accounts Payable of ₨3,498 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on The Searle Co and its competitors.
Is The Searle Co's Accounts Payable too high?
The Searle Co's current Accounts Payable is ₨3,498 Mil. Overall, The Searle Co has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does The Searle Co's Accounts Payable compare to ZTS and UTHR?
The Searle Co's Accounts Payable of ₨3,498 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on The Searle Co and its competitors. The Searle Co's current Accounts Payable is ₨3,498 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Searle Co stock overvalued right now?
Based on GuruFocus' analysis, The Searle Co (KAR:SEARL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨75.81, compared to a current price of ₨90.84 — trading 19.8% above its estimated fair value. The current Accounts Payable is ₨3,498 Mil. The Searle Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For The Searle Co (KAR:SEARL), the current Accounts Payable is ₨3,498 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Searle Co (KAR:SEARL) Overvalued in 2026?

Based on GuruFocus' analysis, The Searle Co stock appears to be overvalued. The current stock price of ₨90.84 is trading 19.8% above its estimated GF Value™ of ₨75.81. GuruFocus considers The Searle Co to be Modestly Overvalued.

Key valuation signals for KAR:SEARL:

  • Accounts Payable: ₨3,498 Mil
  • GF Value™: ₨75.81 vs. price of ₨90.84 (19.8% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the KAR:SEARL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Searle Co Business Description

Address Tipu Sultan Road, Block 7 and 8, Plot No. 1, One IBL Centre, 2nd Floor, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
The Searle Co Ltd is principally engaged in the manufacturing and sale of pharmaceutical, consumer health, and nutritional products. It manufactures and sells products such as Semavi, Dalimab, Extor, Tramal, Rotec, Hylixi, Emsyn, and many more, focusing on various therapeutic areas like cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care. Additionally, the group offers medical devices and disposables, health supplements, and various nutritional consumable products. The majority of the group's revenue consists of pharmaceutical sales. Geographically, it generates maximum revenue from Pakistan, and rest from Sri Lanka, Cambodia, Myanmar, Oman, Vietnam, and other countries.
73GF Score

Get the complete analysis for KAR:SEARL

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨90.84
Price
₨75.81
GF Value